Patent: Nestorone®/estradiol transdermal gel
The invention discloses compositions and methods for ensuring in both women of fertile age where it ensures also a contraception with additional health benefits and in postmenopausal women where it offers a hormonal therapy with additional medical benefits such as the potential for lower risk of thrombosis. The compositions comprising NES as a potent progestational and antiovulatory agent with no androgenic nor estrogenic nor glucocorticoid effect, and combined with estradiol formulated for non-oral transdermal administration as specific daily doses.
Sitruk-Ware, Regine, and Dario Norberto Ramon Carrara. Nestorone®/estradiol Transdermal Gel. US Patent 9,682,087, filed 2010, and issued 2017.
United States Patent 9,682,087